Does Veritas&reg; play a role in breast reconstruction? a case report

Código QR

Does Veritas&reg; play a role in breast reconstruction? a case report

Alessandro Borgognone, Tommaso Anniboletti, Francesco De VitaDepartment of Plastic and Reconstructive Surgery, CTO Hospital, Rome, ItalyAbstract: To reduce operative times and surgical complications in implant-based breast reconstruction, many authors advocate the use of exogenous material (modified...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	De Vita F, Anniboletti T, Borgognone A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/78fc3f8f0dda4ae0a09802f212364960
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Breast reconstruction: current and future options
por: Paul Jr H, et al.
Publicado: (2011)

New approaches in the management of advanced breast cancer &ndash; role of combination treatment with liposomal doxorubicin
por: Iain RJ Macpherson, et al.
Publicado: (2009)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefit
por: Howard-McNatt MM
Publicado: (2013)

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
por: Luiza N. Weis, et al.
Publicado: (2021)

Does Adjunctive Naturopathic Care Decrease Survival Rates in Breast Cancer Patients?
por: Keith I. Block MD
Publicado: (2021)

The role of peroxiredoxin II in chemoresistance of breast cancer cells
por: Wang T, et al.
Publicado: (2014)

Emerging role of brain metastases in the prognosis of breast cancer patients
por: Hambrecht A, et al.
Publicado: (2011)

Role of pertuzumab in the treatment of HER2-positive breast cancer
por: Hubalek M, et al.
Publicado: (2012)

Emerging role of cell polarity proteins in breast cancer progression and metastasis
por: Chatterjee SJ, et al.
Publicado: (2014)

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis
por: Frugtniet B, et al.
Publicado: (2015)

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
por: Oostra DR, et al.
Publicado: (2014)

The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
por: Moya-Horno I, et al.
Publicado: (2015)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
por: Hurvitz SA, et al.
Publicado: (2012)

CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data
por: Jo Anne Zujewski, et al.
Publicado: (2017)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Thomas P. Slavin, et al.
Publicado: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska HA, et al.
Publicado: (2015)

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Sasha E. Stanton, et al.
Publicado: (2021)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Mathilde M. M. Almekinders, et al.
Publicado: (2021)

The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease
por: Francisco Beca, et al.
Publicado: (2021)

An alternative model for (breast) cancer predisposition
por: Erik Teugels, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Optical imaging for breast cancer prescreening
por: Godavarty A, et al.
Publicado: (2015)

Breast carcinomas: variations in sonoelastographic appearance
por: Fleury E, et al.
Publicado: (2014)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3 VNTR polymorphisms and gene co-expression
por: Jaume Fores-Martos, et al.
Publicado: (2021)

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)
por: Yongxian Zhuang, et al.
Publicado: (2021)

Breast cancer in Brazil: epidemiology and treatment challenges
por: Cecilio AP, et al.
Publicado: (2015)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis TA, et al.
Publicado: (2015)